.png)
Press Release
PR Newswire - July 2024
As DEEP continues to grow and evolve, we're excited to share that we've taken some important steps behind the scenes to enable co-creation of digital measures that can offer a whole new perspective into human health.
Slush 2023 - The Most Founder Focused Event On Earth
DEEP is one of the Top100 Startups, selected out of 1000+ applications at Slush 2023! 🚀
We would like to thank everyone who has been co-creating DEEP along its journey. Our mission to change the way human health is measured is being recognized!
September 2023
Recognition In Innovation
The Innovation Award honours outstanding achievements in the deployment and successful implementation of innovative ideas, which could include new ideas for efficiency, productivity and processes.
The focus is on recognising outstanding achievements, delivered in the past three years, in the deployment and successful implementation of innovative ideas, together with rewarding individuals or organisations that embrace new and advanced ways to enhance the regulatory affairs profession.
FINALIST - DEEP-EFPIA collaboration, Finland/Belgium
September 2023
Read on why digital measures matter for drug development
This is a short and enjoyable read on why digital measures matter for drug development - DEEP acknowledges and supports the importance of digital health measures.
"Pharmaceutical companies have not fully utilised the potential of digital measures in clinical trials due to their high cost and lack of standardised applications across therapeutic areas." HealthXL LinkedIn Post
"By embracing digital measures, pharma can accelerate drug development, improve patient outcomes. Pharma can and will continue to compete on assets, but should not compete on (digital) endpoints. We require industry collaborations in order to usher in a new era of medicine." via the HealthXL and Biofourmis Report
November 2023
DIA Europe 2024 | Brussels
12-14 March
Next month at DIA Europe in Brussels, Cathelijne de Gram will be representing DEEP Global Advocacy Network (GAN) with the topic "Strength in Unity: Harnessing the Power of Collaboration for Digital Health Success" in Clinical Trials with Decentralised Elements session. Don't miss the chance to hear more about the learnings and best practices of pre-competitive collaboration with examples from DEEP's ongoing projects and pilot.
Date & Location: 13 March 2024 | Brussels
February 2024
Mobilise-D Conference 2024
March 20
DEEP will be joining to the upcoming Mobilise-D event where they will sharing results, achievements and valuable lessons learned. Mobilise-D is a notable effort in shaping the future direction of digital mobility assessment, and their outcomes are used in the DEEP-EFPIA Pilot that is currently ongoing.
Date & Location: 20 March 2024 | Edinburgh
Attendees from DEEP: Chris Jones, John Batchelor
March 2024
14th Annual Outsourcing in Clinical Trials Europe
7-8 May 2024
This exclusive event brings together attendees from established pharma, large and small, alongside biopharmaceutical companies and allows diving into the operational challenges and innovations in clinical development within the EU.
Date & Location: 7-8 May 2024 | Barcelona
Session Name: Expert Conversation: Strategic Considerations for End-to-End Development of Fit-For-Purpose Digital Measures of Health
Speakers:
-
Chris Jones, DEEP Measures - Moderator
-
Upinder Grewal, Bayer - Industry Expert
-
John Batchelor, DEEP Measures - Science & Technical Expert
May 2024
Webinar Series | Digital Measurement of Nocturnal Scratch: New Developments
Building upon the collaborative work of DiMe in advancing nocturnal scratch as a digital endpoint for atopic dermatitis and the follow-up work conducted in collaboration with DEEP, we will host webinar sessions on:
Webinar 1 (4 June 24): Recent Regulatory Feedback
Webinar 2 (11 June 24): Updated from R&D on Algorithms and Tools
Webinar 3 (18 June 24): Processes, Validation, and Adoption
Speakers:
-
Thorsten Vetter, EMA
-
Wendy Smith Begolka, National Eczema Association
-
Bola Grace, GSK
-
Carrie Northcott, Pfizer
-
Christine Cong Guo, ActiGraph
-
Dina Katabi, MIT, Emeral Innovations
-
Jaydev Thakkar, Biofourmis
-
John Batchelor, DEEP Measures
-
Lada Leyens, Takeda
-
Michael Benecky UCB
-
Steven Xu, Northwestern University, Sonica Health
-
Sylvain Zorman, ActiGraph
-
Tarik Tardibi, Takeda
-
Thomas Switzer, Genentech
-
Lucy Cesnakova, DiMe
-
Jennifer Goldsack, DiMe
Don't miss this opportunity to register now to secure your spot in our webinar series. Join us along with DiMe, EMA and other industry colleagues as we chart a course toward a future where digital measurements guide us toward a deeper understanding of patients' conditions and everyday experiences.
May 2024